Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear
Download results

Showing 1811 to 1820 of 5555 Results

September 07, 2018 Ukraine

$101m City of Kiev debt restructuring - holdout treatment

$101 Million

September 07, 2018 France

Restructuring of the financial indebtedness of the Orchestra-Prémaman Group

$441 Million

September 06, 2018 United States

Genstar Capital to sell Accruent to Fortive

$2 Billion

September 04, 2018 France

AXA S.A announces the Initial Public Offering of AXA Equitable Holdings, Inc., comprising the U.S. life insurance operations of AXA S.A., as well as the successful concurrent offering of $750MM of Mandatory Exchangeable bonds

$3.4 Billion

September 04, 2018 France, Netherlands, Portugal

PT Portugal has reached an agreement with a Consortium including Morgan Stanley Infrastructure and Horizon Equity Partners for the sale of 75% of Towers of Portugal

$792 Million

September 03, 2018 United Kingdom

NSF Group Increases Unitranche Facility to £285m and Super Senior RCF to £45m wtih an Additional £70m of Debt Funding

$446 Million

September 03, 2018 Cyprus, France, Monaco

Monaco Telecom reached an agreement to acquire the entire share capital of MTN Cyprus

$332 Million

September 03, 2018 Luxembourg, Netherlands

BGL BNP Paribas and ABN AMRO Bank N.V. announce that they have signed an agreement concerning the acquisition, by BGL BNP Paribas, of ABN AMRO Bank (Luxembourg) s.a.

Undisclosed

August 31, 2018 Germany, Japan

DPE sells J.H. Ziegler GmbH to Japan’s Teijin Frontier Co., Ltd.

$150 Million

August 31, 2018 France, United Kingdom, United States

Servier acquires Shire’s Oncology business to gain direct commercial access in the US

$2.4 Billion